Next Article in Journal
Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer: Her1–4 and c-Met in Conjunction with the Clinical Features and Human Papillomavirus (p16) Status
Next Article in Special Issue
Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational Study
Previous Article in Journal
Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines
Previous Article in Special Issue
Results and Clinical Interpretation of Germline RET Analysis in a Series of Patients with Medullary Thyroid Carcinoma: The Challenge of the Variants of Uncertain Significance
Article

Effects of the Minimal Extrathyroidal Extension on Early Response Rates after (Adjuvant) Initial Radioactive Iodine Therapy in PTC Patients

1
Department of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany
2
Institute of Pathology, Ludwig-Maximilians-University of Munich, 81377 Munich, Germany
3
Department of Internal Medicine IV, University Hospital, LMU Munich, 81377 Munich, Germany
4
Ambulatory Healthcare Center Dr. Neumaier & Colleagues, Radiology, Nuclear Medicine, Radiation Therapy, 93053 Regensburg, Germany
*
Author to whom correspondence should be addressed.
These two authors contributed equally to this work.
Cancers 2020, 12(11), 3357; https://doi.org/10.3390/cancers12113357
Received: 11 September 2020 / Revised: 6 November 2020 / Accepted: 11 November 2020 / Published: 13 November 2020
(This article belongs to the Special Issue Advances in the Diagnosis and Treatment of Thyroid Carcinoma)
The aim of our retrospective study was to evaluate the impact of minimal extrathyroidal extension on early response rate after (adjuvant) initial radioactive iodine therapy in patients with papillary thyroid cancer (PTC). We found that response rates after radioactive iodine (RAI) therapy in PTC patients were achieved irrespective of minimal extrathyroidal extension (mETE). Nonetheless, the risk of lymph node metastases involvement was significantly higher in the mETE patient group.
Background: Extrathyroidal extension of differentiated thyroid cancer is a poor outcome factor but seems to be less significant in minimal extrathyroidal extension (mETE). However, the impact of mETE on response rate after (adjuvant) initial radioactive iodine (RAI) therapy remains unclear. We therefore compared response rates of patients with classical and follicular variants of papillary thyroid cancer (PTC) according to the updated eighth tumor-node-metastasis (TNM) classification to a control group. Methods: 455 patients with T3 (primary tumor > 4 cm) PTC according to the seventh classification who underwent total thyroidectomy followed by RAI therapy were screened. Patients formerly classified as T3 PTC solely due to mETE were reclassified into patients with T1 (primary tumor ≤ 2 cm) or T2 (primary tumor > 2 cm but ≤ 4 cm) +mETE and compared to a control group of T1/T2 −mETE PTC patients. Results: 138/455 patients were reclassified as T1/2 +mETE and compared to 317/455 T1/T2 −mETE control patients. At initial presentation, +mETE patients showed significantly higher rates of cervical lymph node metastases (p-value 0.001). Response rates were comparable in both groups (p-value n.s.). N1a/N1b-stage (Hazard ratio, HR 0.716; 95% CI 0.536–0.956, p-value 0.024) was identified as an independent prognostic factor for lower response rates. Conclusion: Response rates after RAI therapy were comparable in PTC patients irrespective of mETE but with higher rates of lymph node metastases. View Full-Text
Keywords: differentiated thyroid cancer; papillary thyroid cancer; minimal extrathyroidal extension; radioactive iodine therapy differentiated thyroid cancer; papillary thyroid cancer; minimal extrathyroidal extension; radioactive iodine therapy
Show Figures

Figure 1

MDPI and ACS Style

Ahmaddy, F.; Wenter, V.; Ilhan, H.; Wacker, D.; Unterrainer, M.; Knösel, T.; Bartenstein, P.; Spitzweg, C.; Lehner, S.; Todica, A. Effects of the Minimal Extrathyroidal Extension on Early Response Rates after (Adjuvant) Initial Radioactive Iodine Therapy in PTC Patients. Cancers 2020, 12, 3357. https://doi.org/10.3390/cancers12113357

AMA Style

Ahmaddy F, Wenter V, Ilhan H, Wacker D, Unterrainer M, Knösel T, Bartenstein P, Spitzweg C, Lehner S, Todica A. Effects of the Minimal Extrathyroidal Extension on Early Response Rates after (Adjuvant) Initial Radioactive Iodine Therapy in PTC Patients. Cancers. 2020; 12(11):3357. https://doi.org/10.3390/cancers12113357

Chicago/Turabian Style

Ahmaddy, Freba, Vera Wenter, Harun Ilhan, Daniel Wacker, Marcus Unterrainer, Thomas Knösel, Peter Bartenstein, Christine Spitzweg, Sebastian Lehner, and Andrei Todica. 2020. "Effects of the Minimal Extrathyroidal Extension on Early Response Rates after (Adjuvant) Initial Radioactive Iodine Therapy in PTC Patients" Cancers 12, no. 11: 3357. https://doi.org/10.3390/cancers12113357

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop